ABBV vs ABT

A side-by-side look at ABBV and ABT, updated throughout the trading session.

ABBVABBV Open ABBV on Vela

ABTABT Open ABT on Vela

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…

Live figures are refreshing. Check back in a moment.

ABBV vs ABT: how they differ

AbbVie Inc. (ABBV) and Abbott Laboratories (ABT) are both in the Healthcare sector: ABBV is classified in Drug Manufacturers - General, ABT in Medical - Devices. Both trade on NYSE.

ABBV trades about 5.9 million shares a day on average, against 10.5 million for ABT. ABT has the higher beta (0.58 against 0.28 for ABBV), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABBV paid $6.92 per share in dividends and ABT paid $2.52 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.